Where our facts come from.
Every Pharmacally story is checked against primary sources. These are the references we rely on, in order of preference.
Primary sources we use
Regulators & health agencies
US FDA, European Medicines Agency, CDSCO (India), UK MHRA, WHO and national health ministries: approvals, labels, safety communications and guidance.
Clinical trial registries
ClinicalTrials.gov, the Clinical Trials Registry – India (CTRI) and the EU Clinical Trials Register for trial designs, endpoints and status.
Peer-reviewed literature
Medical and scientific journals, conference abstracts and systematic reviews, with the evidence level stated clearly.
Official company disclosures
Press releases, investor filings and prescribing information — always attributed and never repeated as unverified conclusions.
Professional guidelines
Clinical practice guidelines from specialist societies and national bodies, used for clinical context.
Expert review
Our advisory panel of physicians and public-health specialists reviews health content in their field.
How we cite
Articles link to the documents they are based on, usually in a References section at the end. Where information comes from a company, we say so. If you think a source is missing or wrong, please tell us through the Corrections page.
Report a problem →